In Vivo delivery of CRISPR-Cas9 ribonucleoprotein complex to the retina via a cell penetrating peptide

被引：0
|
作者：
Yanez, Vanessa [1 ]
Kumar-Singh, Rajendra [1 ]
机构：
[1] Tufts Univ, Boston, MA 02111 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1707
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery
    Andersson, Mariette
    Turesson, Helle
    Olsson, Niklas
    Falt, Ann-Sofie
    Ohlsson, Pia
    Gonzalez, Matias N.
    Samuelsson, Mathias
    Hofvander, Per
    PHYSIOLOGIA PLANTARUM, 2018, 164 (04) : 378 - 384
  • [2] CRISPR-Cas9 Ribonucleoprotein Complex Delivery in Plants for DNA Free Genome Editing
    Banakar, Raviraj
    Lee, Keunsub
    Eggenberger, Alan
    Wang, Kan
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2018, 54 : S30 - S30
  • [3] Controlled CRISPR-Cas9 Ribonucleoprotein Delivery for Sensitized Photothermal Therapy
    Chen, Chao
    Ma, Yupei
    Du, Shiyu
    Wu, Yueyao
    Shen, Peiliang
    Yan, Tao
    Li, Xueqing
    Song, Yujun
    Zha, Zhengbao
    Han, Xin
    SMALL, 2021, 17 (33)
  • [4] Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo
    Bykonya, Alesya G.
    Lavrov, Alexander, V
    Smirnikhina, Svetlana A.
    MOLECULAR BIOTECHNOLOGY, 2023, 65 (02) : 181 - 195
  • [5] Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo
    Alesya G. Bykonya
    Alexander V. Lavrov
    Svetlana A. Smirnikhina
    Molecular Biotechnology, 2023, 65 : 181 - 195
  • [6] Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo
    Tao, Yong
    Lamas, Veronica
    Du, Wan
    Zhu, Wenliang
    Li, Yiran
    Whittaker, Madelynn N. N.
    Zuris, John A.
    Thompson, David B. B.
    Rameshbabu, Arun Prabhu
    Shu, Yilai
    Gao, Xue
    Hu, Johnny H. H.
    Pei, Charles
    Kong, Wei-Jia
    Liu, Xuezhong
    Wu, Hao
    Kleinstiver, Benjamin P. P.
    Liu, David R. R.
    Chen, Zheng-Yi
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [7] Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo
    Yong Tao
    Veronica Lamas
    Wan Du
    Wenliang Zhu
    Yiran Li
    Madelynn N. Whittaker
    John A. Zuris
    David B. Thompson
    Arun Prabhu Rameshbabu
    Yilai Shu
    Xue Gao
    Johnny H. Hu
    Charles Pei
    Wei-Jia Kong
    Xuezhong Liu
    Hao Wu
    Benjamin P. Kleinstiver
    David R. Liu
    Zheng-Yi Chen
    Nature Communications, 14
  • [8] CRISPR-Cas9 Delivery with the Ribonucleoprotein Complexes Increased EGFP Editing Efficiency
    Ya. S. Slesarenko
    A. G. Bykonya
    A. A. Anuchina
    M. I. Zaynitdinova
    N. A. Evtushenko
    A. V. Lavrov
    S. A. Smirnikhina
    Neurochemical Journal, 2021, 15 : 390 - 397
  • [9] CRISPR-Cas9 Delivery with the Ribonucleoprotein Complexes Increased EGFP Editing Efficiency
    Slesarenko, Ya. S.
    Bykonya, A. G.
    Anuchina, A. A.
    Zaynitdinova, M. I.
    Evtushenko, N. A.
    Lavrov, A. V.
    Smirnikhina, S. A.
    NEUROCHEMICAL JOURNAL, 2021, 15 (04) : 390 - 397
  • [10] In vivo delivery of CRISPR-Cas9 therapeutics:Progress and challenges
    Matthew Behr
    Jing Zhou
    Bing Xu
    Hongwei Zhang
    Acta Pharmaceutica Sinica B, 2021, 11 (08) : 2150 - 2171
12345